Ketamine as a Treatment for Adolescent Major Depressive Disorder

被引：0
|
作者：
Dwyer, Jennifer [1 ]
Sanacora, Gerard [2 ]
Bloch, Michael [3 ]
机构：
[1] Yale Child Study Ctr, New Haven, CT USA
[2] Yale Univ, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, New Haven, CT 06520 USA
来源：
BIOLOGICAL PSYCHIATRY | 2017年 / 81卷 / 10期
关键词：
Ketamine; Adolescent Depression; Suicide; Antidepressant; Glutamate;
D O I：
10.1016/j.biopsych.2017.02.729
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
1002
引用
收藏
页码：S405 / S405
页数：1
相关论文
共 50 条
  • [21] The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
    Nugent, Allison C.
    Ballard, Elizabeth D.
    Gilbert, Jessica R.
    Tewarie, Prejaas K.
    Brookes, Matthew J.
    Zarate, Carlos A., Jr.
    [J]. FRONTIERS IN PSYCHIATRY, 2020, 11
  • [22] ROLE OF COPPER AND KETAMINE IN MAJOR DEPRESSIVE DISORDER - AN UPDATE
    Slupski, Jakub
    Slupska, Anita
    Szalach, Lukasz P.
    Wlodarczyk, Adam
    Gorska, Natalia
    Szarmach, Joanna
    Jakuszkowiak-Wojten, Katarzyna
    Galuszko-Wegielnik, Maria
    Wilkowska, Alina
    Wiglusz, Mariusz S.
    Cubala, Wieslaw Jerzy
    [J]. PSYCHIATRIA DANUBINA, 2019, 31 : S520 - S523
  • [23] Modafinil Use in an Adolescent With Major Depressive Disorder
    Cakir, Ecem Ozer
    Karakus, Oguz Bilal
    Adak, Ibrahim
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (05) : 514 - 516
  • [24] Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies
    Crisanti, Camilla
    Enrico, Paolo
    Fiorentini, Alessio
    Delvecchio, Giuseppe
    Brambilla, Paolo
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2020, 276 : 1109 - 1118
  • [25] Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder
    Aust, Sabine
    Gaertner, Matti
    Basso, Laura
    Otte, Christian
    Wingenfeld, Katja
    Chae, Woo Ri
    Heuser-Collier, Isabella
    Regen, Francesca
    Cosma, Nicoleta Carmen
    van Hall, Franziska
    Grimm, Simone
    Bajbouj, Malek
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (04) : 529 - 538
  • [26] The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
    Kwasna, Julia
    Cubala, Wieslaw Jerzy
    Kwasny, Aleksander
    Wilkowska, Alina
    [J]. PHARMACOLOGICAL REPORTS, 2024,
  • [27] A CASE OF SUCCESSFUL KETAMINE TREATMENT AFTER ECT FAILURE IN A PATIENT WITH MAJOR DEPRESSIVE DISORDER
    Chatham, Anthony
    Deppe, John
    Subler, Ashley
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (04): : S25 - S25
  • [28] Treatment for major depressive disorder
    Zhang, X.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 : 81 - 81
  • [29] Gray matter alterations in adolescent major depressive disorder and adolescent bipolar disorder
    Long, Xipeng
    Li, Lei
    Wang, Xiuli
    Cao, Yuan
    Wu, Baolin
    Roberts, Neil
    Gong, Qiyong
    Kemp, Graham J.
    Jia, Zhiyun
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2023, 325 : 550 - 563
  • [30] ECT in an adolescent with Down syndrome and treatment-refractory major depressive disorder
    Gensheimer, PM
    Meighen, KG
    McDougle, CJ
    [J]. JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES, 2002, 14 (03) : 291 - 295
12345